Keyword Connections

aβ

Journals

1

1 Nutrients

Research Groups

0

No Research Group Connected

Bibliographies

45

1 Biological Evaluation and Docking Analysis of Potent BACE1 Inhibitors from .

2 Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against HO- and Aβ-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells.

3 Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.

4 Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against HO- and Aβ-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells.

5 Discovery of N-methylpiperazinyl flavones as a novel class of compounds with therapeutic potential against Alzheimer's disease: Synthesis, binding affinity towards amyloid β oligomers (Aβo) and ability to disrupt Aβo-PrP <sup>C</sup> interactions

6 Multifunctional mono-triazole derivatives inhibit Aβ42 aggregation, Cu2+ mediated Aβ42 aggregation and protect against Aβ42 induced cytotoxicity.

7 Design and Synthesis of CNb-targeted Flavones and Analogues with Neuroprotective Potential Against H<inf>2</inf>O<inf>2</inf>- and Aβ<inf>1-42</inf>-Induced Toxicity in SH-SY5Y Human Neuroblastoma Cells

8 Genistein Decreases APP/tau Phosphorylation and Ameliorates Aβ Over- production Through Inhibiting CIP2A.

9 Cell size effects in the molecular dynamics of the intrinsically disordered Aβ peptide.

10 Circadian learning and memory changes in Aβ1-42 induced Alzheimer's mice.

11 Novel Disassembly Mechanisms of Sigmoid Aβ42 Protofibrils by Introduced Neutral and Charged Drug Molecules.

12 Effects of Vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer's disease: A randomised, double-blind, placebo-controlled trial

13 Autism-associated mutations in the Caβ calcium-channel subunit increase Ba-currents and lead to differential modulation by the RGK-protein Gem.

14 Sulforaphane attenuates Aβ oligomers mediated decrease in phagocytic activity of microglial cells.

15 Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation.

16 Vascular consequences of passive Aβ immunization for Alzheimer's disease. Is avoidance of "malactivation" of microglia enough?

17 APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38

18 Standardisierung des Individuellen, Individualisierung des Standardisierten: Versuch einer Klärung aus Anlaβ eines Artikels von Caspar und Grawe

19 Deposition of amyloid β protein (Aβ) subtypes [Aβ40 and Aβ42(43)] in canine senile plaques and cerebral amyoloid angiopathy

20 aβ-induced vulnerability propagates via the brain’s default mode network

21 the role of micrornas in aβ deposition and tau phosphorylation in alzheimer’s disease

22 amyloid β1-42 (aβ1-42) induces the cdk2-mediated phosphorylation of tau through the activation of the mtorc1 signaling pathway while promoting neuronal cell death

23 neuroprotective effects and mechanism of β-asarone against aβ1–42-induced injury in astrocytes

24 Probing the secondary structure of individual Aβ40 amorphous aggregates and fibrils by AFM-IR spectroscopy.

25 mitochondrial protection by the mixed muscarinic/σ1 ligand anavex2-73, a tetrahydrofuran derivative, in aβ25-35 peptide-injected mice, a nontransgenic alzheimer's disease model

26 differential contributions of apoe4 and female sex to bace1 activity and expression mediate aβ deposition and learning and memory in mouse models of alzheimer’s disease

27 unique pharmacological property of isrib in inhibition of aβ-induced neuronal cell death

28 an extract from shrimp processing by-products protects sh-sy5y cells from neurotoxicity induced by aβ25–35

29 cilostazol suppresses aβ-induced neurotoxicity in sh-sy5y cells through inhibition of oxidative stress and mapk signaling pathway

30 impaired memory and evidence of histopathology in ca1 pyramidal neurons through injection of aβ1-42 peptides into the frontal cortices of rat

31 amyloidosis in alzheimer’s disease: the toxicity of amyloid beta (aβ), mechanisms of its accumulation and implications of medicinal plants for therapy

32 can insulin signaling pathways be targeted to transport aβ out of the brain?

33 plasma levels of aβ42 and tau identified probable alzheimer’s dementia: findings in two cohorts

34 glycines from the app gxxxg/gxxxa transmembrane motifs promote formation of pathogenic aβ oligomers in cells

35 the anti-inflammatory effects of lipoxygenase and cyclo-oxygenase inhibitors in inflammation-induced human fetal glia cells and the aβ degradation capacity of human fetal astrocytes in an ex vivo assay

36 choline modulation of the aβ p1-40 channel reconstituted into a model lipid membrane

37 aβ behavior on neuronal membranes: aggregation and toxicities

38 Astrocytes respond to a neurotoxic Aβ fragment with state-dependent Ca2+ alteration and multiphasic transmitter release

39 Gene delivery of a modified antibody to Aβ reduces progression of murine Alzheimer’s disease

40 C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer’s disease

41 Characterisation of the fused silica surface quality with aβ-source

42 Loss of cholinergic innervation differentially affects eNOS-mediated blood flow, drainage of Aβ and cerebral amyloid angiopathy in the cortex and hippocampus of adult mice

43 Neuroprotection in Aβ25-35 -Induced Alzheimer's Disease Model by Hawthorn Leaf Flavonoids

44 Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis.

45 Differences in the Distribution of Aβ in the Brain between U.S. Veterans and Adults aged 62+ and suffering from Alzheimer's Disease.